Home
Conditions
Acute Myeloid Leukemia

Clinical trial condition

Acute Myeloid Leukemia

Explore clinical trials studying Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

1,026 public trials 279 recruiting studies

Refine in advanced search Browse all conditions

Acute Myeloid Leukemia trial results

Recruiting

A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)

NCT06616636

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: The University of Texas MD Anderson Cancer Center Houston, Texas, United States

Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML

NCT05641259

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations: The First Affiliated Hospital of Nanchang University Nanchang, China

First Affiliated Hospital of Soochow University Suzhou, China

Affiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital Zhengzhou, China

View Trial Details

Recruiting

A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia

NCT07255872

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Biological, Prospective Study Evaluating the Dosage of Plasma Cytokines Including the FLT3 Ligand and IL6 of Patients Treated With Non-intensive Chemotherapy

NCT06439199

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations: Nantes University Hospital Nantes, Loire-Atlantique, France

View Trial Details

Recruiting

First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)

NCT07384715

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: Aarhus Universitetshospital - Skejby Aarhus, Denmark

Copenhagen Rigshospitalet Copenhagen, Denmark

Hospital Universitari Vall d'Hebron Barcelona, Spain

Hospital Clínic de Barcelona Barcelona, Spain

View Trial Details

Recruiting

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT07306832

Conditions: Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations: Lucile Packard Children's Hospital /ID# 276015 Palo Alto, California, United States

New York Medical College /ID# 275597 Valhalla, New York, United States

Tristar Centennial Medical Center /ID# 275831 Nashville, Tennessee, United States

Perth Children'S Hospital /ID# 275673 Perth, Western Australia, Australia

View all 13 locations

View Trial Details

Recruiting

Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2

NCT04628026

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Tirol Kliniken GmbH Innsbruck, Austria

Kepler Universitaetsklinikum GmbH Linz, Austria

Ordensklinikum Linz GmbH Linz, Austria

Landeskrankenhaus (LKH) Rankweil, Interne E am Landeskrankenhaus Rankweil Rankweil, Austria

View all 91 locations

View Trial Details

Recruiting

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

NCT07022678

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Arkansas Children's Hospital Little Rock, Arkansas, United States

Valley Children's Hospital Madera, California, United States

Kaiser Permanente-Oakland Oakland, California, United States

Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center Denver, Colorado, United States

View all 39 locations

View Trial Details

Recruiting

A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)

NCT06191978

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

ASTX727, Venetoclax, and Gilteritinib for the Treatment of Newly Diagnosed, Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT05010122

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +10 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Acute Myeloid Leukemia

Acute Myeloid Leukemia trial results

Related conditions